The ENCIRCLE Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 786 participants.

Also called NCT04153292

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 786 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04153292
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada, Israel, Netherlands, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04153292. Non-randomized; no masking; primary purpose treatment. Start 2020-11-12 (actual); primary completion 2027-10-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The ENCIRCLE Trial
Acronym
ENCIRCLE
Condition
Mitral Regurgitation
Condition
Mitral Valve Insufficiency
Intervention (Device)
SAPIEN M3 valve and dock
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct04153292
Content hash
b2f5fa71ea52ef5f45d0851bc7d4db4140ffbe7026474efa05174bfa46daea80